Stocktoria

Dermata Therapeutics, Inc. DRMA

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-08-13

Dermata Therapeutics, Inc. statistics & valuation

Market cap$5.2M
P / B0.8×
Return on equity-121.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-78.20% -159.60% -122.70% -787.10% -121.50% 202020212022202320242025
Shares outstanding
1.9M 8.3M 770115 261998 251725 2.7M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-534.60% -68.00% -138.40% -97.70% -347.70% -96.10% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$39.99 -$80.32 -$8.16 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-96.1%-347.7%-97.7%-138.4%-68.0%-534.6%
Return on equity-121.5%-787.1%-122.7%-159.6%-78.2%101.8%
Current ratio————7.660.16

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.